Identification of GRB2 and GAB1 coexpression as an unfavorable prognostic factor for hepatocellular carcinoma by a combination of expression profile and network analysis

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Zhang, Yanqiong ^a   Li, Zhiwei ^b   Yang, Mei ^b   Wang, Danhua ^a   Yu, Lingxiang ^b   Guo, Chaonan ^b   Guo, Xiaodong ^b   Lin, Na ^a  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^b BEIJING 302 HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; DATABASES, GENETIC; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; GRB2 ADAPTOR PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84894102096     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085170     Document Type: Article

References (50)

1. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108. doi:10.3322/canjclin.55.2.74. PubMed: 15761078. (Pubitemid 40372904)
2. Forner A, Llovet JM, Bruix J (2012) Hepatocellular carcinoma. Lancet 379: 1245-1255. doi:10.1016/S0140-6736(11)61347-0. PubMed: 22353262.
3. Sherman M (2008) Recurrence of hepatocellular carcinoma. N Engl J Med 359: 2045-2047. doi:10.1056/NEJMe0807581. PubMed: 18923166.
4. Thorgeirsson SS, Grisham JW (2002) Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 31: 339-346. doi:10.1038/ng0802-339. PubMed: 12149612. (Pubitemid 35154440)
5. Sakamoto M, Mori T, Masugi Y, Effendi K, Rie I et al. (2008) Candidate molecular markers for histological diagnosis of early hepatocellular carcinoma. Intervirology Suppl 1: 42-45. PubMed: 18544947. (Pubitemid 351821841)
6. Ikoma J, Kaito M, Ishihara T, Nakagawa N, Kamei A et al. (2002) Early diagnosis of hepatocellular carcinoma using a sensitive assay for serum des-gamma-carboxy prothrombin: a prospective study. Hepatogastroenterology 49: 235-238. PubMed: 11941963. (Pubitemid 34289526)
7. Lim HY, Sohn I, Deng S, Lee J, Jung SH et al. (2013) Prediction of Disease-free Survival in Hepatocellular Carcinoma by Gene Expression Profiling. Ann Surg Oncol 20: 3747-3753. doi:10.1245/s10434-013-3070-y. PubMed: 23800896.
8. Wang L, Zang W, Xie D, Ji W, Pan Y et al. (2013) Comparison of hepatocellular carcinoma (HCC), cholangiocarcinoma (CC), and combined HCC-CC (CHC) with each other based on microarray dataset. Tumour Biol 34: 1679-1684. doi:10.1007/s13277-013-0702-6. PubMed: 23532688.
9. Marshall A, Lukk M, Kutter C, Davies S, Alexander G et al. (2013) Global gene expression profiling reveals SPINK1 as a potential hepatocellular carcinoma marker. PLOS ONE 8: e59459. doi:10.1371/journal.pone.0059459. PubMed: 23527199.
10. Chuang HY, Lee E, Liu YT, Lee D, Ideker T (2007) Network-based classification of breast cancer metastasis. Mol Syst Biol 3: 140. PubMed: 17940530.
11. Zhang Y, Wang S, Li D, Zhnag J, Gu D et al. (2011) A systems biologybased classifier for hepatocellular carcinoma diagnosis. PLOS ONE 6: e22426. doi:10.1371/journal.pone.0022426. PubMed: 21829460.
12. Jiang FN, He HC, Zhang YQ, Yang DL, Huang JH et al. (2013) An integrative proteomics and interaction network-based classifier for prostate cancer diagnosis. PLOS ONE 8: e63941. doi:10.1371/journal.pone.0063941. PubMed: 23737958.
13. Su WH, Chao CC, Yeh SH, Chen DS, Chen PJ, et al. (2007) OncoDB.HCC: an integrated oncogenomic database of hepatocellular carcinoma revealed aberrant cancer target genes and loci. Nucleic Acids Res 35(Database issue): D727-D731
14. He B, Qiu X, Li P, Wang L, Lv Q et al. (2010) HCCNet: an integrated network database of hepatocellular carcinoma.Cell Res 20: 732-734. doi:10.1038/cr.2010.67. PubMed: 20479783.
15. Yu XJ, Fang F, Tang CL, Yao L, Yu L et al. (2011) dbHCCvar: a comprehensive database of human genetic variations in hepatocellular carcinoma. Hum Mutat 32: E2308-E2316. doi:10.1002/humu.21595. PubMed: 21936021.
16. Hsu CN, Lai JM, Liu CH, Tseng HH, Lin CY et al. (2007) Detection of the inferred interaction network in hepatocellular carcinoma from EHCO (Encyclopedia of Hepatocellular Carcinoma genes Online). BMC Bioinformatics 8: 66. doi:10.1186/1471-2105-8-66. PubMed: 17326819.
17. Lee L, Wang K, Li G, Xie Z, Wang Y et al. (2011) Liverome: a curated database of liver cancer-related gene signatures with self-contained context information. BMC Genomics 12(Suppl 3): S3. doi: 10.1186/1471-2164-12-3. PubMed: 22369201.
18. Chen JY, Mamidipalli S, Huan T (2009) HAPPI: an online database of comprehensive human annotated and predicted protein interactions. BMC Genomics 10 Suppl 1: S16. doi:10.1186/1471-2164-10-S1-S16. PubMed: 19594875.
19. Matthews L, Gopinath G, Gillespie M, Caudy M, Croft D et al. (2009) Reactome knowledgebase of human biological pathways and processes. Nucleic Acids Res 37: D619-D622. doi:10.1093/nar/gkn863. PubMed: 18981052.
20. Brown KR, Jurisica I (2005) Online predicted human interaction database. Bioinformatics 21: 2076-2082. doi:10.1093/bioinformatics/bti273. PubMed: 15657099. (Pubitemid 40668047)
21. Aranda B, Achuthan P, Alam-Faruque Y, Armean I, Bridge A et al. (2010) The IntAct molecular interaction database in 2010. Nucleic Acids Res 38: D525-D531. doi:10.1093/nar/gkp878. PubMed: 19850723.
22. Keshava Prasad TS, Goel R, Kandasamy K, Keerthikumar S, Kumar S et al. (2009) Human Protein Reference Database - 2009 update. Nucleic Acids Res 37: D767-D772. doi:10.1093/nar/gkn892. PubMed: 18988627.
23. Ceol A, Chatr Aryamontri A, Licata L, Peluso D, Briganti L et al. (2010) MINT, the molecular interaction database: 2009 update. Nucleic Acids Res 38: D532-D539. doi:10.1093/nar/gkp983. PubMed: 19897547.
24. Lehne B, Schlitt T (2009) Protein-protein interaction databases: keeping up with growing interactomes. Hum Genomics 3: 291-297. PubMed: 19403463.
25. Beuming T, Skrabanek L, Niv MY, Mukherjee P, Weinstein H (2005) PDZBase: a protein-protein interaction database for PDZ-domains. Bioinformatics 21: 827-828. doi:10.1093/bioinformatics/bti098. PubMed: 15513994. (Pubitemid 40439423)
26. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W et al. (2003) DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4: 3. doi:10.1186/gb-2003-4-5-p3.
27. Wixon J, Kell D (2000) The Kyoto encyclopedia of genes and genomes - KEGG. Yeast 17: 48-55. PubMed: 10928937. (Pubitemid 30406798)
28. Valente TW, Fujimoto K (2010) Bridging: locating critical connectors in a network. Soc Networks 32: 212-220. doi:10.1016/j.socnet.2010.03.003. PubMed: 20582157.
29. Wuchty S, Almaas E (2005) Evolutionary cores of domain co-occurrence networks. BMC Evol Biol 5: 24. doi: 10.1186/1471-2148-5-24. PubMed: 15788102.
30. Narayanan T, Gersten M, Subramaniam S, Grama A (2011) Modularity detection in protein-protein interaction networks. BMC Res Notes 4: 569. doi:10.1186/1756-0500-4-569. PubMed: 22206604.
31. Guo X, Xiong L, Zou L, Zhao J (2012) Upregulation of bone morphogenetic protein 4 is associated with poor prognosis in patients with hepatocellular carcinoma. Pathol Oncol Res 18: 635-640. doi: 10.1007/s12253-011-9488-2. PubMed: 22350792.
32. Guo X, Xiong L, Sun T, Peng R, Zou L et al. (2012) Expression features of SOX9 associate with tumor progression and poor prognosis of hepatocellular carcinoma. Diagn Pathol 7: 44. doi: 10.1186/1746-1596-7-44. PubMed: 22515642.
33. Guo X, Xiong L, Zou L, Sun T, Zhang J et al. (2012) L1 cell adhesion molecule overexpression in hepatocellular carcinoma associates with advanced tumor progression and poor patient survival. Diagn Pathol 7: 96. doi:10.1186/1746-1596-7-96. PubMed: 22888955.
34. Li S, Zhang ZQ, Wu LJ, Zhang XG, Li YD et al. (2007) Understanding ZHENG in traditional Chinese medicine in the context of neuro-endocrine-immune network. IET. Syst Biol 1: 51-60. (Pubitemid 46779218)
35. Lee EK, Kim DG, Kim JS, Yoon Y (2011) Cell-cycle regulator Cks1 promotes hepatocellular carcinoma by supporting NF-κB-dependent expression of interleukin-8. Cancer Res 71: 6827-6835. doi: 10.1158/0008-5472.CAN-10-4356. PubMed: 21917729.
36. McKillop IH, Schmidt CM, Cahill PA, Sitzmann JV (1997) Altered expression of mitogen-activated protein kinases in a rat model of experimental hepatocellular carcinoma. Hepatology 26: 1484-1491. doi: 10.1002/hep.510260615. PubMed: 9397988. (Pubitemid 27520013)
37. Reimers M (2010) Making informed choices about microarray data analysis. PLoS Comput Biol 6: e1000786. PubMed: 20523743.
38. Newman MEJ (2010) Networks: An Introduction. USA: Oxford University Press. 266 pp.
39. Garbay C, Liu WQ, Vidal M, Roques BP (2000) Inhibitors of Ras signal transduction as antitumor agents. Biochem Pharmacol 60: 1165-1169. doi:10.1016/S0006-2952(00)00428-7. PubMed: 11007954.
40. Giubellino A, Gao Y, Lee S, Lee MJ, Vasselli JR et al. (2007) Inhibition of tumor metastasis by a growth factor receptor bound protein 2 Src homology 2 domain-binding antagonist. Cancer Res 67: 6012-6016. doi:10.1158/0008-5472.CAN- 07-0022. PubMed: 17616655. (Pubitemid 47037478)
41. Dharmawardana PG, Peruzzi B, Giubellino A, Burke TR Jr, Bottaro DP (2006) Molecular targeting of growth factor receptor-bound 2 (Grb2) as an anti-cancer strategy. Anticancer Drugs 17: 13-20. Available online at: doi:10.1097/01.cad. 0000185180.72604.ac. PubMed: 16317285.
42. Wang Z, Ge L, Wang M, Carr BI (2007) Grb2-associated binder-1 plays a central role in the hepatocyte growth factor enhancement of hepatoma growth inhibition by K vitamin analog compound 5. Hepatology 46: 2003-2013. doi:10.1002/hep.21900. PubMed: 18046719.
43. Hoeben A, Martin D, Clement PM, Cools J, Gutkind JS (2013) Role of GRB2-associated binder 1 in epidermal growth factor receptor-induced signaling in head and neck squamous cell carcinoma. Int J Cancer 132: 1042-1050. doi:10.1002/ijc.27763. PubMed: 22865653.
44. Liu Y, Rohrschneider LR (2002) The gift of Gab. FEBS Lett 515: 1-7. doi:10.1016/S0014-5793(02)02425-0. PubMed: 11943184. (Pubitemid 34273887)
45. Nishida K, Hirano T (2003) The role of Gab family scaffolding adapter proteins in the signal transduction of cytokine and growth factor receptors. Cancer Sci 94: 1029-1033. doi:10.1111/j.1349-7006.2003.tb01396.x. PubMed: 14662016. (Pubitemid 38035515)
46. McDonald CB, Bhat V, Mikles DC, Deegan BJ, Seldeen KL et al. (2012) Bivalent binding drives the formation of the Grb2-Gab1 signaling complex in a noncooperative manner. FEBS J 279: 2156-2173. doi: 10.1111/j.1742-4658.2012. 08600.x. PubMed: 22536782.
47. Yoon SY, Jeong MJ, Yoo J, Lee KI, Kwon BM et al. (2001) Grb2 dominantly associates with dynamin II in human hepatocellular carcinoma HepG2 cells. J Cell Biochem 84: 150-155. PubMed: 11746524. (Pubitemid 33101518)
48. Kondo A, Hirayama N, Sugito Y, Shono M, Tanaka T et al. (2008) Coupling of Grb2 to Gab1 mediates hepatocyte growth factor-induced high intensity ERK signal required for inhibition of HepG2 hepatoma cell proliferation. J Biol Chem 283: 1428-1436. PubMed: 18003605.
49. Takeishi K, Taketomi A, Shirabe K, Toshima T, Motomura T et al. (2012) Diacylglycerol kinase alpha enhances hepatocellular carcinoma progression by activation of Ras-Raf-MEK-ERK pathway. J Hepatol 57: 77-83. doi:10.1016/j.jhep. 2012.02.026. PubMed: 22425622.
50. Wang S, Huang X, Li Y, Lao H, Zhang Y et al. (2011) RN181 suppresses hepatocellular carcinoma growth by inhibition of the ERK/MAPK pathway. Hepatology 53: 1932-1942. doi:10.1002/hep.24291.PubMed: 21391225.